comparemela.com
Home
Live Updates
Catherinej Lee - Breaking News
Pages:
Latest Breaking News On - Catherinej lee - Page 1 : comparemela.com
Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late
JSP191 is well tolerated with no treatment-related severe adverse events in 17 subjects with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).
United states
Salt lake city
John mullaly
Lori muffly
Andrew artz
Catherinej lee
Jasper therapeutics inc
Cellular therapy meetings
William lis
Low dose irradiation
Fludarabine conditioning is well tolerated
Facilitates chimerism
Minimal residual disease
Older adults
Jasper therapeutics
Nasdaq jspr
vimarsana © 2020. All Rights Reserved.